无针给药装置市场规模、份额及成长分析（按类型、应用和地区划分）－2026-2033年产业预测

预计到 2024 年，无针药物输送装置市场规模将达到 150.7 亿美元，到 2025 年将达到 161.1 亿美元，到 2033 年将达到 274.8 亿美元，预测期（2026-2033 年）的复合年增长率为 6.9%。

全球无针给药装置市场可望以创新解决方案革新医疗保健产业。摒弃传统针头不仅降低了针头使用的风险，还能显着减轻患者的不适感。对无痛、以患者为中心的给药方式的需求日益增长，尤其是在自体免疫疾病和糖尿病等慢性病管理领域，这正推动着市场成长。人口老化和对自行注射药物的需求也是促成成长要素。经皮吸收贴片和喷射注射器等创新技术提高了给药的便利性和精准度，推动了无针给药装置的广泛应用。儘管医疗机构仍然是重要的市场区隔领域，并将病患舒适度放在首位，但居家医疗机构的使用也在迅速成长。然而，儘管市场前景光明，但高昂的研发成本和监管方面的挑战可能会阻碍市场扩张。

推动无针给药装置市场发展的因素

无针给药装置市场经历了显着成长，这主要得益于不断涌现的创新装置，这些装置具有更高的精准度和效率。这项发展主要归功于无针给药技术的持续进步。经皮吸收贴片、微针和喷射注射器方式带来的不适感，显着提升患者的整体体验。

无针给药装置市场的限制因素

由于医疗设备业监管要求严格，无针给药装置市场面临许多挑战。这些创新产品的核准流程通常漫长而复杂，对製造商造成了许多障碍。虽然这些法规对于确保病患安全和有效给药至关重要，但它们也会增加研发成本，延长生产和分销时间。企业在应对合规复杂性的过程中，产品上市可能出现延误，这严重阻碍因素了产业成长和创新。

无针给药装置的市场趋势

随着技术进步，无针给药装置的应用范围从胰岛素和疫苗等传统用途扩展到专科治疗药物和生物製药，市场正经历显着成长。这一市场趋势反映了对能够确保药物精准控制给药的创新解决方案日益增长的需求。无针装置的多功能性正日益受到认可，使其得以应用于包括慢性病管理和儿童护理在内的多个治疗领域，在这些领域，最大限度地减少疼痛和提高患者依从性至关重要。在不断变化的医疗需求和偏好的驱动下，随着相关人员不断创新并探索新的应用领域，该市场有望迎来显着成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术分析
• 专利分析

全球无针给药装置市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 吸入器技术
• 经皮吸收贴片技术
• 新型无针技术

全球无针给药装置市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 疫苗接种
• 疼痛管理
• 胰岛素治疗糖尿病
• 儿童注射
• 其他的

全球无针给药装置市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• PenJet（USA）
• Zealand Pharma（Denmark）
• UCB SA（Belgium）
• PharmaJet（USA）
• 3M（USA）
• Verdict Media Limited（UK）
• INJEX Pharma AG（Germany）
• Antares Pharma（USA）
• Endo Pharmaceuticals Inc.（USA）
• Bioject Medical Technologies, Inc.（USA）
• Crossject SA（France）
• MannKind Corporation（USA）
• Mika Medical Co.（South Korea）
• Halozyme, Inc.（USA）
• Akra Dermojet（Turkey）
• Zydus Group（India）
• Ferring BV（Switzerland）
• Gerresheimer AG（Germany）
• AptarGroup, Inc.（USA）
• MIIST Therapeutics（USA）

结论与建议

Needle-free Drug Delivery Devices Market size was valued at USD 15.07 Billion in 2024 and is poised to grow from USD 16.11 Billion in 2025 to USD 27.48 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global market for needle-free drug delivery devices is poised to revolutionize the healthcare sector with its innovative solutions. By eliminating traditional needles, these devices mitigate the risks associated with needle use and significantly reduce patient discomfort. Rising demand for pain-free and patient-centric drug administration, particularly in managing chronic conditions like autoimmune disorders and diabetes, is driving market growth. Furthermore, the aging population and the need for self-injected drugs are contributing factors. Innovations, such as transdermal patches and jet injectors, enhance convenience and precision, boosting their popularity. While healthcare facilities remain the primary market segment prioritizing patient comfort, homecare settings are rapidly gaining ground. However, high development costs and regulatory challenges may pose barriers to market expansion, despite its promising trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Needle-free Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Needle-free Drug Delivery Devices Market Segments Analysis

Global Needle-free Drug Delivery Devices Market is segmented by Type, Application and region. Based on Type, the market is segmented into Inhaler technology, Transdermal patch technology and Novel needle-free technologies. Based on Application, the market is segmented into Vaccine delivery, Pain management, Insulin delivery for diabetes, Pediatric injections and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Needle-free Drug Delivery Devices Market

The Needle-free Drug Delivery Devices market is experiencing significant growth, driven by the advent of innovative devices characterized by enhanced precision and efficiency. This evolution is largely attributed to ongoing advancements in needle-free drug delivery technologies. The emergence of sophisticated solutions such as transdermal patches, micro-needles, and jet injectors exemplifies this progress, allowing for versatile applications across various medical scenarios. As technology continues to advance, these devices are becoming increasingly precise, catering to a broader range of therapeutic needs and improving the overall patient experience by reducing the discomfort associated with traditional needle-based methods.

Restraints in the Needle-free Drug Delivery Devices Market

The needle-free drug delivery devices market faces significant challenges due to stringent regulatory requirements that govern the medical device industry. The process of obtaining approval for these innovative products is often lengthy and complex, creating hurdles for manufacturers. While these regulations are essential for ensuring patient safety and the efficacy of drug delivery, they can also lead to increased development costs and protracted timelines for production and distribution. As companies navigate the intricacies of compliance, the potential for delays in bringing products to market poses a considerable restraint on industry growth and innovation.

Market Trends of the Needle-free Drug Delivery Devices Market

The Needle-free Drug Delivery Devices market is experiencing significant expansion beyond traditional applications like insulin and vaccines, as advancements in technology broaden their use in specialized therapeutics and biologics. This market trend reflects a growing demand for innovative solutions that ensure controlled and accurate drug administration. The versatility of needle-free devices is being increasingly recognized, enabling their adoption in various therapeutic areas, including chronic disease management and pediatric care, where minimizing pain and enhancing patient compliance are crucial. As industry stakeholders continue to innovate and explore new applications, the market is poised for substantial growth, driven by evolving healthcare needs and preferences.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis
• Patent Analysis

Global Needle-free Drug Delivery Devices Market Size by Type & CAGR (2026-2033)

• Market Overview
• Inhaler technology
• Transdermal patch technology
• Novel needle-free technologies

Global Needle-free Drug Delivery Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Vaccine delivery
• Pain management
• Insulin delivery for diabetes
• Pediatric injections
• Others

Global Needle-free Drug Delivery Devices Market Size & CAGR (2026-2033)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• PenJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zealand Pharma (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCB S.A. (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verdict Media Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INJEX Pharma AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antares Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crossject SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MannKind Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mika Medical Co. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Halozyme, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akra Dermojet (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring B.V. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MIIST Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations